The Drug Enforcement Administration is preparing for its Dec. 2 hearing on cannabis rescheduling by starting the process of picking witnesses to speak. The federal agency notified a number of parties that they have been approved to testify at the hearing, according to a report in Marijuana Moment. The National …
The Massachusetts Cannabis Control Commission named David Lakeman, a former commission staffer who’s been working as a cannabis regulator in Illinois the past four years, to be its new executive director during a meeting on Monday, after a months-long search that kicked off in May. Lakeman will take over for …
Australian biotech firm Tryptamine Therapeutics Limited (ASX: TYP) secured A$6 million in new funding through a strategic placement. The placement, priced at A$0.02 per share, was backed by cornerstone investors that included Merchant Biotech Fund and biotech investor Daniel Tillett, who will join the company’s board as a non-executive director, …
With early voting well underway in Florida, the fate of the state’s Amendment 3, which would usher in recreational cannabis sales for adults 21 and older, is being decided. But questions linger about the measure’s timeline and how Gov. Ron DeSantis’ administration will approach what could become the nation’s third-largest …